Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7

2006 Archive

Published on Dec 29, 2006 by Edgar Snyder
Heartburn Drugs

Taking one of the popular heartburn drugs such as Nexium, Prevacid or Prilosec? If you’re over the age of 50 take heed—taking the drugs for more than a year can raise your chances of a broken hip, a British study found.

Published on Dec 20, 2006 by Edgar Snyder
Over-the-Counter Drugs

The Food and Drug Administration (FDA) proposed stronger warning labels for over-the-counter drugs that are more dangerous than previously indicated. Labels will include warnings about liver failure resulting from overuse of acetaminophens and gastrointestinal bleeding from overuse of nonsteroidal anti-inflammatories (NSAIDS).

Published on Dec 18, 2006 by Edgar Snyder

According to internal Eli Lilly documents and e-mails, sales reps were encouraged to play down Zyprexa’s risks for obesity and diabetes. They were also encouraged to promote the drug to treat dementia, even though it was only approved to treat schizophrenia and bipolar disorder.

Published on Dec 15, 2006 by Edgar Snyder

Critics claim that the study for a new drug that Merck intends to market in lieu of Vioxx is flawed. The drug was tested against an older pain killer known to raise heart risks, when a more logical study would have compared Arcoxia to a medicine that does not raise heart risks such as Naproxen, or Aleve.

Published on Dec 13, 2006 by Edgar Snyder

The Food and Drug Administration (FDA) will decide if antidepressant labels should include a warning for patients that the drugs can increase suicidal thoughts and behavior in patients up to age 24. Currently, antidepressants carry a “black box” warning label for children and adolescents.

Published on Dec 08, 2006 by Edgar Snyder
Younger Antidepressant User

The younger the antidepressant user, the more likely they are to have suicidal thoughts. That’s the conclusion the Food and Drug Administration (FDA) had after they researched 372 clinical studies involving 11 antidepressants to see if increased suicidal thoughts and behavior in children continued through to adulthood. The study involved over 100,000 patients and dated back to 1985.

Published on Dec 07, 2006 by Edgar Snyder

Despite two manufacturers of drug-coated stents claiming the benefits of their devices outweigh the risks, the Food and Drug Administration (FDA) believes they pose a risk of death and raise other safety concerns. Clotting risks and patient precautions associated with drug-coated stents are among the topics planned for discussion at the FDA's meeting with Boston Scientific, Johnson & Johnson, and an outside panel of medical experts.

Published on Dec 04, 2006 by Edgar Snyder

Pfizer officially announced that it is halting development of what was to be one of their most promising drugs, torcetrapib. The drug was the first in a new class of drugs known as CETP inhibitors, which would have helped increase the amount of “good” cholesterol, or HDL, reducing heart disease.

Published on Dec 01, 2006 by Edgar Snyder

If you are pregnant or plan to become pregnant, you may want to stay clear of the antidepressant drug Paxil, according to the American College of Obstetricians and Gynecologists. This warning comes a year after the Food and Drug Administration (FDA) and GlaxoSmithKline reclassified the antidepressant because studies of pregnant women showed a risk to the fetus.

Published on Nov 17, 2006 by Edgar Snyder

The Food and Drug Administration’s (FDA) pediatric advisory committee met to review safety reports on various drugs. The panel is reviewing 16 drugs to determine if they should be used in pediatric patients.

Published on Nov 14, 2006 by Edgar Snyder

The Food and Drug Administration (FDA) is suggesting a revision to Tamiflu’s U.S. label that will include a warning for close supervision of all patients, especially children. This suggested label change comes after 103 reports from Japan of odd behavior mostly in children and included three deaths from falls.

Published on Nov 09, 2006 by Edgar Snyder

Throw away your store-brand 500mg acetaminophen caplets. The Food and Drug Administration (FDA) announced a voluntary recall by Perrigo Company of their over-the-counter pain reliever due to small metal fragments found in a small number of these store-brand caplets. Approximately 11 million bottles containing varying quantities of acetaminophen 500mg caplets are affected by the recall. Tylenol, a name brand acetaminophen, is not affected by this recall.

Published on Nov 08, 2006 by Edgar Snyder
ER Visits

A new national study reports that 17,000 children visit emergency rooms annually due to school bus-related accidents. Most frequently the children suffered cuts and broken bones, but thankfully, most injuries were not life-threatening.

Published on Nov 06, 2006 by Edgar Snyder
Tomatoes - Salmonella

State and Centers for Disease and Control Prevention (CDC) investigators found that tomatoes consumed in restaurants led to the recent salmonella outbreak in 21 states. In all, 183 cases have been reported to the CDC.

Published on Nov 02, 2006 by Edgar Snyder
Otho Evra

Several women are suing the maker of a popular birth-control patch, Ortho Evra, saying it caused serious illness and even led to the death of a young woman. Forty-four women in all are suing Ortho-McNeil makers of Ortho Evra.

Published on Oct 20, 2006 by Edgar Snyder

After numerous reports indicated preschoolers were being prescribed psychiatric drugs such as Ritalin, the government started a long-term study to document the side effects of the drugs in children. The National Institute of Mental Health now claims the study indicated that doctors “proceed with caution” when prescribing preschoolers psychiatric drugs.

Published on Oct 18, 2006 by Edgar Snyder
ER Visit

Each year, over 700,000 Americans go to emergency rooms for reactions to commonly used medications. The study is to be published in the Journal of the American Medical Association.

Published on Oct 16, 2006 by Edgar Snyder

Prompted by the dangers associated with Vioxx in 2004, the Food and Drug Administration (FDA) asked the Institute of Medicine to review their drug safety system. With the results in, the institute is recommending several changes.

Published on Oct 12, 2006 by Edgar Snyder
pill bottles

The Food and Drug Administration (FDA) forgot one important factor when they began a study on the risks associated with attention-deficit hyperactivity drugs (ADHD) in children and adults—a budget. This FDA study and others like it may soon stop due to lack of funding by the agency.

Published on Oct 05, 2006 by Edgar Snyder

A Philadelphia jury found that the hormone replacement therapy (HRT) drug Prempro was the cause of a woman’s breast cancer. The next phase of the trial will decide if Wyeth, Prempro’s maker, failed to properly warn about the drug’s dangers.

Free Case Review
First Name
Last Name
Briefly describe your injuries